Skip to main content
. 2021 Nov 10;19(4):228–249. doi: 10.1038/s41569-021-00629-x

Fig. 4. Timeline of major developments in the field of atherosclerosis nanomedicine.

Fig. 4

Milestones in the development of nanoparticle-based imaging contrast agents and therapeutics for atherosclerosis diagnosis and treatment. NP, nanoparticle; USPIO, ultrasmall superparamagnetic iron oxide.

HHS Vulnerability Disclosure